{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:40:29Z","timestamp":1782970829808,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01-MH116039"],"award-info":[{"award-number":["R01-MH116039"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.schres.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T23:49:25Z","timestamp":1683676165000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation"],"prefix":"10.1016","volume":"256","author":[{"given":"Ian M.","family":"Raugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanka","family":"Ristanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pelletier-Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay A.","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.04.015_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0920-9964(95)00070-4","article-title":"A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale","volume":"19","author":"Addington","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb5000","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpsychires.2017.11.004","article-title":"Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups","volume":"97","author":"Ahmed","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/schbul\/sby050","article-title":"Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia","volume":"45","author":"Ahmed","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02294359","article-title":"Factor analysis and AIC","volume":"52","author":"Akaike","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.schres.2023.04.015_bb5005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/S0007125000291496","article-title":"The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations","author":"Andreasen","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.schres.2023.04.015_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1037\/1040-3590.10.2.176","article-title":"Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample","volume":"10","author":"Antony","year":"1998","journal-title":"Psychol. Assess."},{"key":"10.1016\/j.schres.2023.04.015_bb5010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-3956(93)90036-2","article-title":"Validation of the 16-item Negative Symptom Assessment","volume":"27","author":"Axelrod","year":"1993","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0025","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1037\/abn0000259","article-title":"Explicit and implicit reinforcement learning across the psychosis spectrum","volume":"126","author":"Barch","year":"2017","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2023.04.015_bb0030","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","article-title":"Comparative fit indexes in structural models","volume":"107","author":"Bentler","year":"1990","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb5015","doi-asserted-by":"crossref","DOI":"10.1007\/s00406-023-01551-8","article-title":"The effects of the COVID-19 pandemic on hallucinations and delusions in youth at clinical high-risk for psychosis and outpatients with schizophrenia","author":"Berglund","year":"2023","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2023.04.015_bb0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4088\/JCP.08m04250yel","article-title":"Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study","volume":"71","author":"Bobes","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2011.09.006","article-title":"Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study","volume":"133","author":"Chang","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1521\/pedi.2010.24.4.516","article-title":"Toward a more psychometrically sound brief measure of schizotypal traits: introducing the SPQ-brief revised","volume":"24","author":"Cohen","year":"2010","journal-title":"J. Personal. Disord."},{"key":"10.1016\/j.schres.2023.04.015_bb0050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/schbul\/sbaa065","article-title":"Digital phenotyping of negative symptoms: the relationship to clinician ratings","volume":"47","author":"Cohen","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb5020","doi-asserted-by":"crossref","DOI":"10.1037\/abn0000554","article-title":"Heterogeneity of emotional experience in schizophrenia: Trait affect profiles predict clinical presentation and functional outcome","author":"Cowan","year":"2020","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2023.04.015_bb0055","article-title":"Persistent negative symptoms in youth at clinical high risk for psychosis: a longitudinal study","author":"Devoe","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/schbul\/sbv161","article-title":"Self-evaluation of negative symptoms: a novel tool to assess negative symptoms","volume":"42","author":"Dollfus","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2019.07.012","article-title":"Specificity and sensitivity of the self-assessment of negative symptoms (SNS) in patients with schizophrenia","volume":"211","author":"Dollfus","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eurpsy.2014.01.007","article-title":"Impact of primary negative symptoms on functional outcomes in schizophrenia","volume":"29","author":"Fervaha","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/acps.12289","article-title":"Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia","volume":"130","author":"Fervaha","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2023.04.015_bb0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.psychres.2015.09.002","article-title":"Distress related to subclinical negative symptoms in a non-clinical sample: role of dysfunctional attitudes","volume":"230","author":"Fervaha","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0085","series-title":"Structured Clinical Interview For DSM-5(R) Personality Disorders (SCID-5-PD)","author":"First","year":"2015"},{"key":"10.1016\/j.schres.2023.04.015_bb0090","series-title":"Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV)","author":"First","year":"2015"},{"key":"10.1016\/j.schres.2023.04.015_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.comppsych.2010.07.001","article-title":"Schizotypal traits and depressive symptoms in nonclinical adolescents","volume":"52","author":"Fonseca-Pedrero","year":"2011","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2013.03.024","article-title":"Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms","volume":"147","author":"Fulford","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapsychiatry.2019.4779","article-title":"Prevention of psychosis: advances in detection, prognosis, and intervention","volume":"77","author":"Fusar-Poli","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2020.01.012","article-title":"Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states","author":"Glenth\u00f8j","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archgenpsychiatry.2011.1269","article-title":"Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence","volume":"69","author":"Gold","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpsgos.2021.05.008","article-title":"Secondary sources of negative symptoms in those meeting criteria for a clinical high-risk syndrome","author":"Gupta","year":"2021","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.schres.2023.04.015_bb5025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1037\/0002-9432.76.3.395","article-title":"Mental health in adolescence: is America's youth flourishing?","volume":"76","author":"Keyes","year":"2006","journal-title":"Am. J. Orthopsychiatry"},{"issue":"6","key":"10.1016\/j.schres.2023.04.015_bb5030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127740","article-title":"Instruments measuring blunted affect in schizophrenia: a systematic review","volume":"10","author":"Kilian","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.schres.2023.04.015_bb0135","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/schbul\/sbj053","article-title":"The NIMH-MATRICS consensus statement on negative symptoms","volume":"32","author":"Kirkpatrick","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/schbul\/sbq059","article-title":"The brief negative symptom scale: psychometric properties","volume":"37","author":"Kirkpatrick","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/appi.ajp.2012.12010109","article-title":"The clinical assessment interview for negative symptoms (CAINS): final development and validation","volume":"170","author":"Kring","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb5035","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2005.11.024","article-title":"Anxiety and depression symptoms in psychometrically identified schizotypy","volume":"83","author":"Lewandowski","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2016.02.035","article-title":"Current developments and challenges in the assessment of negative symptoms","volume":"186","author":"Lincoln","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0160","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.comppsych.2012.12.001","article-title":"The motivation and pleasure scale-self-report (MAP-SR): reliability and validity of a self-report measure of negative symptoms","volume":"54","author":"Llerena","year":"2013","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.schres.2020.03.012","article-title":"Clarifying the direction of impact of negative symptoms and neurocognition on prospective work functioning in psychosis: a 20-year longitudinal study","volume":"220","author":"Luther","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb5040","article-title":"Adherence to recommended health and social distancing precautions during the COVID-19 pandemic in individuals with schizophrenia and youth at clinical high-risk for psychosis","author":"Macdonald","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/08039480801959307","article-title":"Negative symptoms in schizophrenia: a review","volume":"62","author":"M\u00e4kinen","year":"2008","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0175","series-title":"The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up","author":"McGlashan","year":"2010"},{"key":"10.1016\/j.schres.2023.04.015_bb0180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1037\/abn0000461","article-title":"From neuroimaging to daily functioning: a multimethod analysis of reward anticipation in people with schizophrenia","volume":"128","author":"Moran","year":"2019","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2023.04.015_bb5045","doi-asserted-by":"crossref","first-page":"766692","DOI":"10.3389\/fpsyt.2021.766692","article-title":"Primary and secondary negative symptoms in schizophrenia","volume":"12","author":"Mosolov","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2023.04.015_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2017.01.055","article-title":"Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms (PINS)","volume":"189","author":"Pelletier-Baldelli","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psychres.2012.02.018","article-title":"Negative symptoms in individuals at clinical high risk of psychosis","volume":"196","author":"Piskulic","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12888-019-2314-1","article-title":"Spanish validation of the self-evaluation of negative symptoms scale SNS in an adolescent population","volume":"19","author":"Rodr\u00edguez-Testal","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1207\/s15327906mbr2502_4","article-title":"Structural model evaluation and modification: an interval estimation approach","volume":"25","author":"Steiger","year":"1990","journal-title":"Multivariate Behav. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0205","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/schbul\/sbn167","article-title":"Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study","volume":"36","author":"Strauss","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0210","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2010.10.015","article-title":"Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia","volume":"69","author":"Strauss","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.comppsych.2012.05.009","article-title":"Negative symptoms and depression predict lower psychological well-being in individuals with schizophrenia","volume":"53","author":"Strauss","year":"2012","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0220","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jamapsychiatry.2018.2475","article-title":"The latent structure of negative symptoms in schizophrenia","volume":"75","author":"Strauss","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2023.04.015_bb0225","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/schbul\/sby169","article-title":"Reconsidering the latent structure of negative symptoms in schizophrenia: a review of evidence supporting the 5 consensus domains","volume":"45","author":"Strauss","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb5050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/schbul\/sbx066","article-title":"A transdiagnostic review of negative symptom phenomenology and etiology","volume":"43","author":"Strauss","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0230","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/schbul\/sby133","article-title":"Network analysis reveals the latent structure of negative symptoms in schizophrenia","volume":"45","author":"Strauss","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2023.04.015_bb0235","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.schres.2020.04.019","article-title":"A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis","volume":"222","author":"Strauss","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.04.015_bb0240","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-021-01260-0","article-title":"The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia","volume":"272","author":"Strauss","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2023.04.015_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02291170","article-title":"A reliability coefficient for maximum likelihood factor analysis","volume":"38","author":"Tucker","year":"1973","journal-title":"Psychometrika"},{"key":"10.1016\/j.schres.2023.04.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2020.101971","article-title":"Validation and extension of the motivation and pleasure scale-self report (MAP-SR) across the schizophrenia spectrum in the Chinese context","volume":"49","author":"Wang","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2023.04.015_bb0255","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/0011000006288127","article-title":"Scale development research","volume":"34","author":"Worthington","year":"2006","journal-title":"Couns. Psychol."},{"key":"10.1016\/j.schres.2023.04.015_bb0260","series-title":"Evaluating Cutoff Criteria of Model Fit Indices for Latent Variable Models With Binary and Continuous Outcomes","author":"Yu","year":"2002"}],"updated-by":[{"DOI":"10.1016\/j.schres.2025.05.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}},{"DOI":"10.1016\/j.schres.2026.04.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000}},{"DOI":"10.1016\/j.schres.2026.04.007","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:43:31Z","timestamp":1763757811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":63,"alternative-id":["S0920996423001688"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.04.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}